The treatment of adult low-grade glioma
Shi-shi Chen;Jin-quan Li Department of Neurosurgery;The First Affiliated Hospital of Soochow University;Suzhou 215006;P.R.China

..............page:277-281

Advances in research of the functional roles of neural cell adhesion molecule L1 (L1CAM) in glioblastoma stem cells
Dan-yang Tang;Wei-jiang Zhao Center of Neuroscience;Shantou university medical college;Shantou 515041;P.R.China

..............page:282-285

Tumorigenesis vis-a-vis Toll-like receptors
Liao-yuan Zheng1;2;Meng Zhang1;Wei-ping Li1 1.Department of Neurosurgery;Shenzhen Second Hospital;Shenzhen 518035;P.R.China.2.Shantou University Medical College;Shantou 515041;P.R.China

..............page:286-290

zhong guo kang ai xie hui shen jing zhong liu zhuan ye wei yuan hui di san jie wei yuan hui wei yuan ming dan

..............page:291-292

zhong guo kang ai xie hui shen jing zhong liu zhuan ye wei yuan hui di san jie wei yuan hui qing nian wei yuan ming dan

..............page:293

zhe jiang da xue yi xue yuan fu shu di er yi yuan jiao zhi liu duo xue ke lian he zhen zhi zhong xin jian jie

..............page:294

wo guo zhu ming shen jing wai ke zhuan jia zhao shi guang jiao shou

..............page:212

Inhibition of heat shock protein response enhances PS-341-mediated glioma cell death
Yun-ke Bi1;Dan-dan Gao2;Chen Shen1;Da-yong Han1;Yao-hua Liu1;Shi-guang Zhao1 1.Department of Neurosurgery;the First Affiliated Hospital of Harbin Medical University;Harbin 150001;P.R.China;2.The Second Department of Medical Oncology;Photodynamic Therapy Center of Heilongjiang Province;the Third Affiliated Hospital of Harbin Medical University;Harbin 150081;P.R.China

..............page:217-222

The role of AQP-1 and VEGF in the formation of hemangioblastomas
Bin Yu;Xu-hui Hui;Yan Ju;Liang-xue Zhou Department of Neurosurgery;West China Hospital of Sichuan University;Chengdu 610041;P.R.China

..............page:223-227

The expression level and correlation of MMP-9 and IL-17 in pituitary tumor tissue
Lu-Bin Qiu1;Hai-Jun Wang2;Yong-Jun Zhu1;Dong-sheng He2;Ya-tang Wang1;Jian-Ming Yang1 1.Department of Otolaryngology;The Second Affiliated Hospital of Anhui Medical University;Hefei 230601;P.R.China;2.Department of Neurosurgery;The First Affiliated Hospital of Sun Yat-sen University;Guangzhou 510080;P.R.China

..............page:228-233

Phase Ⅱ trial of temozolomide plus interferon-β in recurrent malignant glioma patients
Qun-ying Yang;Cheng-cheng Guo;Ke Sai;Chao Ke;Xian-heng Zhang;Jiang Wang;Yong-gao Mu;Zhong-ping Chen State Key Laboratory of Oncology in South China;Department of Neurosurgery/Neuro-oncology;Cancer Center;Sun Yat-sen University;Guangzhou 510060;P.R.China

..............page:234-239

Prognostic factors for patients with glioma located in brain eloquent areas
Hao Zhu1;2;Hong Shen2;Jin-fang Xu2;Yong-jian Zhu2;Li Li2;Xiao-dong Fang3 1.Department of Neurousurgery;the Fourth Affiliated Hospital of Anhui Medical University;Hefei 230000;P.R.China;2.Department of Neurousurgery;the Second Affiliated Hospital of School of Medicine of Zhejiang University;Hangzhou 310009;P.R.China;3.Department of Neurousurgery;Binjiang Hospital;the Second Affiliated Hospital of School of Medicine of Zhejiang University;Hangzhou 310000;P.R.China

..............page:240-245

Microsurgery of tumors in the fourth ventricle (31 cases report)
Wen-bo Zhang;Xiao-ping Liu;Xiang Lai;Min Ye;Jin-xing Huang;Feng Xie;Ming-li Liang Department of Neurosurgery;Meizhou Hospital;Meizhou 514031;P.R.China

..............page:246-249

Salvage gamma knife stereotactic radiosurgery followed by bevacizumab for recurrent glioblastoma multiforme: a case-control study
Park KJ;Kano H;Iyer A;Liu X;Niranjan A;Flickinger JC;Lieberman FS;Lunsford LD;Kondziolka D.Department of Neurosurgery;College of Medicine;Korea University;Seoul;Korea.

..............page:227

Relation between bevacizumab dose intensity and high-grade glioma survival:a retrospective study in two large cohorts
Lorgis V;Maura G;Coppa G;Hassani K;Taillandier L;Chauffert B;Apetoh L;Ladoire S;Ghiringhelli F.Department of Medical Oncology;Georges Francois Leclerc Cancer Center;1 rue du professeur Marion;Dijon 21000;France.

..............page:239

zhong guo kang ai xie hui shen jing zhong liu zhuan ye wei yuan hui di shi jie xue shu hui yi zuo di qi jie zhong han shen jing zhong liu shuang bian xue shu jiao liu hui yi zheng wen tong zhi

..............page:245

2013 nian shen jing zhong liu guo ji hui yi ( ying wen )

..............page:271

2013’CSNO-SNO Joint Meeting

..............page:285

Perioperative nursing in the awake craniotomy for glioma in language cortex
Min Yang1;Li Chen1*;Xi-bin Zhang2;Shao-long Fang2;Jin-xi Zhao2;Ning-hui Zhao2 1.Department of Operaitng Room;The Second Affiliated Hospital of Kunmin Medical College;Kunming 650101;P.R.China;2.Department of Neurosurgery;The Second Affiliated Hospital of Kunmin Medical College;Kunming 650101;P.R.China

..............page:250-252

Drug resistance target gene regulated by microRNAs in glioma
Yan-chang Sun1;2;Jie Wang1;Zong-ping Zhang2;Zhong-ping Chen1 1.Department of Neurosurgery;Sun Yat-sen University Cancer Center;Guangzhou 510060;P.R.China;2.Department of Neurosurgery;Guangdong Medical University Zhanjiang Cancer Institute and Hospital;Zhanjiang 524002;P.R.China

..............page:253-260

Beacizumab in high grade glioma
Ji-an Yang;Qian-xue Chen Department of Neurosurgery;Renmin Hospital of Wuhan University;Wuhan 430060;P.R.China

..............page:261-266

The cross-talk between Wnt and Shh signaling pathways by Atoh1 in Medulloblastoma
Yu Li1;Li Tang2 1.Department of Pathology;Chongqing Medical University;Chongqing 400016;2.Department of Pathophysiology;Chongqing Medical University;Chongqing 400016

..............page:267-271

Src proteins and their inhibitors in tumor research progress
Jing-chao Wu1;Jin-huan Wang1;Xue-quan Feng2 1.Tianjin Huanhu Hospital;Tianjin 300060;P.R.China;2.Department of Neurosurgery;Tianjin First Center Hospital;Tianjin 300192;P.R.China

..............page:272-276